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Abstract
AIM: To test the hypothesis that enhancement of the 
activity of heme oxygenase can interfere with processes 
of fibrogenesis associated with recurrent liver injury, we 
investigated the therapeutic potential of over-expression 
of heme oxygense-1 in a CCl4-induced micronodular cir-
rhosis model. 
Methods: Recombinant adeno-associated viruses car-
rying rat HO-1 or GFP gene were generated. 1×1012 vg 
of adeno-associated viruses were administered through 
portal injection at the time of the induction of liver fi-
brosis. 
Results: Conditioning the rat liver with over-expres-
sion of HO-1 by rAAV/HO-1 significantly increased the 
HO enzymatic activities in a stable manner. The develop-
ment of micronodular cirrhosis was significantly inhib-
ited in rAAV/HO-1-transduced animals as compared to 
controls. Portal hypertension was markedly diminished 
in rAAV/HO-1-transduced animals as compared to con-
trols, whereas there are no significant changes in systolic 
blood pressure. This finding was accompanied with im-
proved liver biochemistry, less infiltrating macrophages 
and less activated hepatic stellate cells (HSCs) in rAAV/
HO-1-transduced livers. 
ConClusIons: Enhancement of HO activity in the liv-
ers suppresses the development of cirrhosis. 
© 2006 The WJG Press. All rights reserved.
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Heme oxygenase �H��� �s a �a�e���m���ng en�yme ��a�       
c�eaves p�o�ox�dan� �eme �n�o equ�mo�a� amoun�s of  
ca�bon monox�de �C���, b���ve�d�n/b����ub�n, and f�ee   
fe��ous ��on [1,2]. Up �o da�e, ���ee �sofo�ms of  H� �ave 
been �den��f�ed. Among of  ��em, H��1 and H��2 a�e 
exp�essed �n ��ve�s. H��2 exp�esses cons���u��ve�y �n �epa�
�ocy�e and func��ons as an �mpo��an� en�yme �n ca�a�y��ng 
��e endogenous and exogenous �eme. In con��as�, H��1 
�s an �nduc�b�e fo�m of  H� �n ��ve�s [3]. A���oug� exp�es�
s�on of  H��1 �n ��e ��ve� �s p��ma���y �es���c�ed �o a sub�
popu�a��on of  Kupffe� ce��s [3,4], ��e p�o�e�n �s exp�essed �n 
bo�� pa�enc�yma� and pa���cu�a��y non�pa�enc�yma� ��ve� 
ce��s, and ��e�efo�e �esu��s �n ��g�e� en�yma��c ac��v���es of  
H� unde� s��ess cond���ons [4]. T�e cy�op�o�ec��ve effec�s 
of  en�anced H� ac��v���es �n ��ve� m�g�� be ���oug� ��e 
mec�an�sms assoc�a�ed w��� ��s ca�a�y��c p�oduc�s. A�� of  
��s ���ee ca�a�y��c p�oduc�s can con���bu�e ��e p�o�ec��ve ef�
fec�s of  H� [5�7]. 
H��1 was �nduced �n ��e ��ve�s w��� c����os�s [8]. 
I� was ��oug�� �o be an adop��ve �esponse �o ox�da��ve 
s��esses, �nf�amma�o�y �nsu��s of  pe�s�s�en� o� �ecu��en� 
��ve� �nju�y as we�� as ��e �espons�veness �o ��e �nc�ease of  
�n��as�nuso�da� �es�s�ance. H��1 was ma�n�y exp�essed �n 
Kupffe� ce��s, s�nuso�da� endo��e��a� ce��s, s�e��a�e ce��s and 
�n a pa�� of  �epa�ocy�e �n ��ve�s w��� c����os�s [8,9]. H��1 
was a�so exp�essed �n vascu�a� sys�em ��a� m�g�� con���b�
u�e �o ��e deve�opmen� of  �emodynam�c c�anges �n ��e 
�a�s w��� c����os�s [9]. In add���on, ��g�e� �eve�s of  C� 
p�oduc��on m�g�� be assoc�a�ed w��� ��e deve�opmen� of  
�epa�opu�mona�y synd�ome �n pa��en�s w��� c����os�s [10]. 
T�us, �� becomes con��ove�sy w�e��e� ��e exp�ess�on of  
H��1 o� en�ancemen� of  H� ac��v���es con���bu�e �o ��e 
pa��op�ys�o�og�ca� c�anges �n ��e deve�opmen� of  c����o�
s�s, o� w�e��e� H��1 func��ons as �omeos�a��c mo�ecu�e �n 
con��o���ng of  d�sease p�og�ess�on. To e�uc�da�e ��e �o�e of  
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H��1 �n ��e con�ex� of  �ecu��en� �epa�oce��u�a� �nju�y and 
��e deve�opmen� of c����os�s, �e�e we �a�e ��e advan�age       
of  adeno�assoc�a�ed v��a� vec�o� �o �nc�ease ��e ove�a�� H� 
en�yma��c ac��v��y of  ��e ��ve� �n a s�ab�e manne� and �o 
�nves��ga�e ��e effec�s of  H��1 �n ��e d�sease p�og�ess�on 
�n ca�bon �e��ac��o��de �CC�4����nduced c����os�s mode�.   
MAtErIALS And MEtHodS
Generation of recombinant adeno-associated viral vectors 
(r���s�� 
rAAVs were produced and purified as previously described [11]. 
In b��ef, a fu����eng�� H��1 gene o��g�na��y c�oned f�om       
��e sp�een of  a ���� �a� o� ��e �epo��e� gene ���� was         
�nse��ed �n�o ��e vec�o� p�asm�d �o cons��uc� pSNAV1/
���� o� pSNAV1/H��1. �AAV/���� o� �AAV/H��1 was 
gene�a�ed �n BHK�21 ce��s �Ame��can Type Cu��u�e Co��ec�
��on, Manassas, VA�� by ��ansfec��on of  vec�o� p�asm�d and 
subsequen� �escue �AAVs �se�o�ype 2�� by co��nfec��on w��� 
recombinant HSV1-rc/∆UL2, which is essential for viron 
packaging. A large scale of  rAAV was purified as described [12]. 
�nimal model and gene delivery protocol
Inb�ed ���� �a�s �230�250 g�� we�e pu�c�ased f�om ��e   
An�ma� Ins���u�e of  Med�ca� Sc�oo� Hannove�, �e�many 
and we�e ma�n�a�ned �n ��e �abo�a�o�y An�ma� Un�� of     
��e Un�ve�s��y of  Hong Kong. T�e s�udy was app�oved by 
��e Comm���ee on ��e Use of  ��ve An�ma�s fo� Teac��ng 
and Resea�c�, ��e Un�ve�s��y of  Hong Kong. M�c�onodu�a� 
��ve� c����os�s �n ���� �a�s was �nduced us�ng a p�o�oco� 
desc��bed p�ev�ous�y [13]. In b��ef, p�en�oba�b��a� sod�um 
(35 mg/L) was given one week before the first dose of  CCl4 
�n o�de� �o �nc�ease ��e sens���v��y of  ��e �a� ��ve� �o CC�4 
and was p�esen� �n d��n��ng wa�e� �n ��e w�o�e pe��od of    
�nduc��on. A �o�a� of 9 doses of CC�      4 �0.2 m�/�g pe� w��� 
we�e g�ven �o ��e �a�s �n��agas���ca��y. �AAVs �1×1012v.g.�� 
was g�ven ���oug� ��e po��a� ve�n of  �a�s a� ��e ��me pen�o�
barbital was given in drinking water and �� d before the first           
dose of  CC�4. 
Liver biochemistry, histology, immunohistochemistry and 
ELIS� 
Se�um samp�es we�e co��ec�ed a� ��e end po�n� of  expe���
men�s. T�e ac��v���es of  a�an�ne am�no��ansfe�ase �A�T�� 
and �o�a� b����ub�n �n ��e p�asma we�e measu�ed �n ��e 
Depa��men� of  C��n�ca� B�oc�em�s��y, ��e Un�ve�s��y of  
Hong Kong. ��ve� samp�es we�e snap f�o�en and s�o�ed a� 
�75 ℃ un��� fu���e� app��ca��ons. ��ve m�c�ome�e�s of f�o�   
�en sec��ons we�e used fo� �ema�oxy��n and eos�n s�a�n�ng,   
Masson’s ���c��ome s�a�n�ng, and �mmuno��s�oc�em�s��y.   
The area of  fibrotic tissues in the cross section of livers� �� � �� �� �       
was measu�ed by ��e compu�e� sof�wa�e �Me�aMo�p� �m�
ag�ng sys�em, Un�ve�sa� Imag�ng Co�po�a��on, ��A�� af�e� 
Masson’s trichrome, collagen 1α and fibronectin staining. 
A�� measu�emen�s we�e done �n a doub�e�b��nd manne�   
w��� a� �eas� 20 a�eas/��ve� �f�b�o��c a�ea, o��g�na� 200×�� 
�n ��e 5 ��ve�s/g�oup. Mouse an����a� �D1 ��nf����a��ng 
mac�op�age��, an����D2 ���ssue �es�den��a� mac�op�age��, 
an���H��1 ��SA�111�� monoc�ona� an��bod�es and po�y�
clonal anti-TGF-β1, anti-desmin, anti-collagen 1α, and  
an���f�b�onec��n an��bod�es �Se�o�ec ��d., �xfo�d, UK; 
S��essgene, V�c�o��a, B����s� Co�umb�a, Canada; C�em�con, 
Temecu�a, CA; San�a C�u�, CA�� we�e app��ed �n ���s s�udy 
fo� �mmuno��s�oc�em�s��y us�ng ��e s�anda�d �o�se�ad�s�   
pe�ox�dase p�o�oco�. Se�um mac�op�age m�g�a��on �n��b��
�o�y fac�o� �MI��� �eve� was de�ec�ed by ��ISA acco�d�ng 
�o ��e �ns��uc��on of  manufac�u�e� �C�em�con��. 
Measurement of portal and systolic blood pressure
An�ma�s we�e anes��es��ed w��� �e�am�ne �100 mg/�g, �p��      
and Rompun �0.2 mg/�g, �p��. ��o��a� p�essu�e and sys�o��c 
b�ood p�essu�e we�e measu�ed by d��ec��y �n��oduc�ng 24� 
Ang�oca��® �BD B�osc�ences, San Jose, CA�� �n�o ��e po��a�  
vein or abdominal aorta and connecting with a saline filled   
s��a�n gauge ��ansduce�. T�e s�gna�s we�e mon��o�ed by 
Co��n B���408 Ma�� III �Japan�� and we�e se� �o �e�o befo�e 
��e measu�emen�. 
HO enzymatic activity
T�e H� en�yma��c ac��v��y was measu�ed by ��e p�oduc� 
��on of  m�c�osoma� b����ub�n �n ��e ��ve�. ��o�en samp�es 
of  ��ve�s we�e �omogen��ed �n �ce�co�d suc�ose and T���
HC� buffe�. M�c�osoma� pe��e� was ob�a�ned af�e� cen���fu�     
ga��on and was ��en �e�suspended �n MgC�2�po�ass�um 
p�osp�a�e buffe�. Samp�e p�o�e�n was fu���e� �ncuba�ed 
w��� ��e �eac��on m�x�u�e con�a�n�ng �a� ��ve� cy�oso�, �e�
m�n, g�ucose�6�p�osp�a�e, g�ucose�6�p�osp�a�e de�yd�o�
genase and NAD��H �S�gma�A�d��c�, S�. �ou�s, M��� fo� 
60 m�nu�es a� 37 ℃. T�e gene�a�ed b����ub�n was measu�ed 
us�ng spec��op�o�ome��y. T�e �eve� of  b����ub�n p�oduc�
��on was demons��a�ed by ��e �a��o of  samp�e/no�ma� 
��ve�. 
RNase protection assay
T�e mRNA �eve� of �a�ge� genes was de�e�m�ned by        
RNase p�o�ec��on assay acco�d�ng �o ��e �ns��uc��on of  
manufac�u�e� �R�boQuan� ���, BD B�osc�ences ���a�m�n�
gen, San D�ego, CA��. In b��ef, �o�a� RNA of  ��ansduced 
and non���ansduced ��ve� samp�es we�e ex��ac�ed and pu���
f�ed us�ng Rneasy ��� �Q�agen, H��den, �e�many��. T��ee 
m�c�og�ams of  RNA/samp�es we�e �yb��d��ed w��� com�
p��men�a�y [32��]UT�� �abe�ed ��bop�obes ove�n�g��. T�e 
p�obes we�e d�ges�ed w��� Rnase and we�e �oaded on a 
dena�u�ed po�yac�y�am�de ge�. T�e �ad�oac��ve s�gna�s we�e 
then detected by exposure to X-ray film (BioMax, Kodak, 
Rochester, NY) and quantified by phosphorimaging (Strom, 
Mo�ecu�a� Dynam�cs, Sunnyva�e, CA��. 
Statistical analysis
Da�a we�e demons��a�ed as mean ± S�M. �ne�way AN��
VA was used �o compa�e ��e d�ffe�ence of  means be�ween 
��e expe��men�a� g�oups w��� ��e Bonfe��on�’s t��es�. 
P < 0.05 was considered statistically significant.
rESuLtS 
r���-mediated stable HO enzymatic activity in rat liver 
To en�ance H� ac��v��y �n a s�ab�e manne�, we adm�n�
�s�e�ed ��e �AAV ca��y�ng �a� H��1 cDNA �o ��e ��ve� 
���oug� po��a� �njec��on. Af�e� ��e �njec��on, a �a�ge num�
www.wjgnet.com
be� of  H��1 pos���ve non�pa�enc�yma� ce��s we�e found �n 
bo�� �AAV/���� and �AAV/H��1���ansduced ��ve�s on d 
7 �17.7 ± 0.5 ce��s/mm2 ve�sus 10.8 ± 0.7 ce��s/mm2, n = 3��. 
Howeve�, ��e numbe� of  pos���ve ce��s dec�eased d�ama���
ca��y �o a �eve� s�m��a� �o no�ma� ��ve�s �n �AAV/���� 
��ansduced ��ve� on day 30, w�e�eas ��e�e was a s�gn�f��
can��y �a�ge� numbe� of  H��1�pos���ve non�pa�enc�yma� 
ce��s �n �AAV/H��1���ansduced ��ve�s �3.9 ± 0.8 ce��s/mm2 
vs 5.8 ± 1.0 ce��s/mm2, n = 3, P < 0.05; ��gu�es 1A and 1B��. 
No H��1 pos���ve �epa�ocy�e was found �n bo�� �AAV/
���� and �AAV/H��1 ��ea�men� g�oups on d 7. T�e ex�
pression of  HO-1 in hepatocyte was first detected sporadi�
ca��y on d 14 af�e� po��a� �njec��on of  �AAV/H��1, w�e�e�
as ��e�e was no H��1 pos���ve �epa�ocy�e �n �AAV/�����
��ansduced ��ve�s �da�a no� s�own��. Mo�e H��1 pos���ve 
�epa�ocy�es cou�d be de�ec�ed �n �AAV/H��1���ansduced 
��ve�s on d 30 �2.2 ± 0.3 ce��s/mm2, n = 3, P < 0.05��, w�e�eas 
��ey �ema�ned unde�ec�ab�e �n �AAV/�������ansduced ��v�
e�s ���gu�es 1A and 1B��. To eva�ua�e ��e b�o�og�ca� ac��v��y 
of  ��ansduced H��1 �n ��e ��ve�s, we de�e�m�ned ��e en�
�yma��c ac��v��y of  H� by measu��ng ��e gene�a�ed b����u�
b�n of  m�c�osoma� p�o�e�n �so�a�ed f�om ��e ��ve�s. T�e�e 
was a s�gn�f�can� �nc�ease of  H� ac��v��y of  ��e �AAV�
��ansduced ��ve�s on d 7 ���e ea���es� ��me po�n� ��a� we 
de�ec�ed��. Bo�� �AAV/���� and �AAV/H��1 ��ansduced 
��ve�s s�owed �nc�eased amoun� of  gene�a�ed b����ub�n �n 
�so�a�ed m�c�osoma� p�o�e�ns. Imp�ess�ve�y, ��e amoun� of  
gene�a�ed b����ub�n �0.9 fo�d ove� ��e basa� �eve� of  no�ma� 
�a� ��ve��� �ema�ned e�eva�ed �n ��e �AAV/H��1 ��ea�men� 
g�oup and sus�a�ned fo� ove� 3 mo of  obse�va��on ��me. 
In con��as�, ��e amoun� of  gene�a�ed b����ub�n dec�eased 
�o ��e �eve� of  no�ma� �a�s �n ��e �AAV/���� ��ea�men� 
group on d 14. (Figure 1C). This suggests the specificity of  
�AAV/H��1 �n ��e �nduc��on of  s�ab�e H� ac��v��y �n �a� 
��ve�. 
Enhancement of HO activity suppressed the development 
of cirrhosis in rats 
In��agas���ca��y adm�n�s��a��on of  CC�4 �o adu�� ���� �a�s 
fo� 9 w� �esu��ed �n ��e fo�ma��on of  m�c�onodu�a� c���
��os�s. To fu���e� eva�ua�e ��e effec�s of  e�eva�ed H� 
ac��v��y on ��e deve�opmen� of  c����os�s, we exam�ned 
va��ous pa�ame�e�s �e�a��ng �o c����os�s af�e� ove��exp�es�
s�on of  H��1 �n �a� ��ve� by �AAV gene ��ansfe� ���gu�e 
2A��. H�s�o�og�ca� exam�na��on s�owed mass�ve amoun� 
of  fibrotic tissues accumulated in the portal tract areas of  
non���ansduced o� �AAV/�������ansduced ��ve�s and �ed 
�o ��e fo�ma��on of  m�c�onodu�a� c����os�s accompan�ed 
w��� po��a� �ype��ens�on and �owe� sys�o��c b�ood p�es�
su�e �n ��e majo���y of  �a�s. �AAV/H��1 gene ��ansfe� 
markedly diminished the amount of  accumulated fibrotic 
��ssues as s�own �n Masson’s ���c��ome �MT�� s�a�n�ng and 
�mmuno��s�oc�em�s��y. No m�c�onodu�a� c����os�s was 
formed and only minimal fibrotic tissues could be found 
�n ��e po��a� ��ac� a�eas of  �AAV/H��1���ansduced ��ve�s 
(Figure 2B). Analysis of  fibrotic areas using the computer 
sof�wa�e s�owed ��a� ��e�e was s�gn�f�can��y �ess f�b�o��c 
e�emen� depos���on �n ��e �AAV/H��1���ansduced ��ve� 
(��.9% ± 0.9% by MT staining, 3.1% ± 2.6% by collagen 1α 
Figure 1  A: The expression patterns of HO-1 in the livers after portal injection of 
rAAV/HO-1 in LEW rats. Red arrow indicated the HO-1-positive non-parenchymal 
cells; green arrow indicated the hepatocyte; B: The quantification of the HO-1 
positive cells in the liver after administration of rAAV/HO-1. Data were presented 
as number of HO-1 positive cells per mm2; n = 3-5, mean ± SE, aP<0.05; C: The 
HO enzymatic activity of rAAV/GFP or rAAV/HO-1 transduced livers. The data 
were demonstrated as the amount of generated bilirubin of microsomal protein 
from liver tissues and were shown as the fold changes over the normal rat liver, 
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Figure 2  A: The model to induce micronodular cirrhosis in LEW rat. The rAAVs 
were injected through the portal vein shortly before the induction; B: The histology 
and immunohistochemistry of the livers with or without treatment at the 10th 
week (H-E, original magnification ×40; MT: Masson’s trichrome stiaining, the 
fibrotic elements were stained in green, original 100×; collagen 1 and fibronectin 
staining, original magnification ×100); C: The measurement of fibrotic area in 
the livers at the 10th week by the computer software as described in Materials 
& Methods. Data were shown as mean±SE, n = 5, bP < 0.001; D and E: The 
systolic and portal pressure of rats after induction of liver cirrhosis with or without 
treatments. The data were shown as mean±SE, n = 10, dP < 0.001.
s�a�n�ng, 4.4% ± 1.2% by f�b�onec��n s�a�n�ng, P < 0.001��. 
In con��as�, �n ��e ��ve�s of  non���ea�men� o� �AAV/���� 
��ea�ed g�oups, ��e�e was a ��g�e� �eve� of  f�b�o��c e�e�
men� depos���on �22.2% ± 5.8% o� 20.8 %± 3.8% by MT 
staining, 21.9 %± 5.��% or 24.5 %± 2.8% by collagen 1α 
s�a�n�ng, 24.1 %± 4.4% o� 21.1% ± 3.6% by f�b�onec��n 
staining, Figure 2C). In addition, the beneficial effects of  
H��1 on ��e deve�opmen� of  ��ve� c����os�s cou�d be �e�
flected by the reduction of  portal hypertension (8.0 ± 0.8 
mmHg ve�sus 13.3 ± 0.4 mmHg �n ��e non���ea�men� 
g�oup and 13.8 ± 0.6 mmHg �n ��e �AAV/���� ��ea�men� 
g�oup, P < 0.001), whereas there was no significant differ�
ence a� ��e sys�o��c b�ood p�essu�e �81.7 ± 0.3 mmHg�� �n 
compa��son �o non���ea�men� �81.8 ± 0.6 mmHg�� o� vec�o� 
con��o�s �87.0 ± 0.2 mmHg, P > 0.31, ��gu�es 2D and 2���. 
Stable HO activity protected against CCl4-mediated recur-
rent liver injury
Repea�ed adm� �s��a��on of  CC�4 �o adu�� �a�s �ed �o c��on�
�c ��ve� �nju�y w��� e�eva�ed p�asma �eve� of  �o�a� b����ub�n 
(no treatment group: 5��.25 ± 6.95 μmol/L; rAAV/GFP 
group: 60.5±4.8�� μmol/L) and ALT (non-treatment group: 
4 522 ± 334 IU/�; �AAV/���� g�oup: 6 552 ± 1 363 IU/�, 
n = 5��. Inc�eas�ng H� ac��v��y �n ��e ��ve� by �AAV/H��1 
s�gn�f�can��y �mp�oved ��e ��ve� func��on of  �a�s unde� 
�ong��e�m CC�4 �ox�c��y, ��e amoun� of  �o�a� b����ub�n and 
A�T dec�eased d�ama��ca��y �n ��e �AAV/H��1���ea�ed 
�a�s �n compa��son �o non���ea�men� o� �AAV/���� con�
trols (total bilirubin: 6.20 ± 3.49 μmol/L; ALT: 199.6 ±
80.5 IU/�, n = 5, P < 0.005, ��gu�es 3A and 3B��. To fu���e� 
exam�ne ��e p�o�ec��ve effec�s of  ove��exp�ess�ng H��1 �n 
��e ��ve�s, we de�e�m�ned ��e ��ansc��p� �eve� of  apop�o��c 
genes and ene�gy exc�anges of  ��ve�s unde� �ong��e�m 
CC�4 �ox�c��y. Rnase p�o�ec��on assay s�owed ��e ��ansc��p� 
level of  Fas, caspase 3, and BAX genes significantly dimin�
�s�ed �n ��e �AAV/H��1���ansduced ��ve�s �n = 3, P < 0.05, 
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Figure 3  A and B: The liver function of rats with or with treatment under long-term 
CCl4 toxicity was presented by the determination of plasma ALT and total bilirubin 
level. The data was shown as mean±SEM, n = 5-10, aP<0.001; C and D: The 
representative picture of the expression patterns of apoptotic genes in the livers at 
the 10th week. The mRNA level of genes was detected by RNase protection assay. 
The quantification of the expression level was measured by phosphoimager as 
described in Materials & Methods. The data were shown as mean ± SE, n = 3-5, 
bP<0.05; E: The ATP level of the livers of rats with or without treatments at the 10th 
wk, n  =  5-10, dP<0.001.
��gu�es 3C and 3D��, w�e�eas ��ese genes we�e s��ong�y ex�
p�essed �n ��e non���ansduced o� �AAV/�������ansduced 
��ve�s. T�e benef�c�a� effec�s of  H��1 on CC�4�med�a�ed 
c��on�c ��ve� �nju�y we�e a�so s�own by ��e �mp�ovemen� 
of  ��ve� ene�gy exc�anges. �ve��exp�ess�on of  H��1 by 




























































































































































































�n �AAV/H��1��ansduced ��ve� �n compa��son w��� non�
��ea�men� o� �AAV/�������ansduced ��ve�s of  �a�s unde� 
�ong��e�m CC�4 �ox�c��y �n = 3�5, P   < 0.05; ��gu�e 3���. 
Stable HO activity suppresses the pro-inflammatory and 
pro-fibrogenic responses in CCl4-treated rats
To characterize the effects of  HO-1 on the chronic inflam�
ma�o�y �esponse fo��owed by ��ve� �nju�y, we exam�ned ��e 
��s�opa��o�og�ca� pa�ame�e�s of  ��ve� ��ssues and ��ansc��p� 
o� p�o�e�n �eve� of  p�o��nf�amma�o�y cy�o��ne�MI�. A 
�a�ge amoun� of  �D1�pos���ve ��nf����a��ng�� mac�op�ages 
accumu�a�ed �n ��e po��a� ��ac� a�eas �n ��e non���ansduced 
o� �AAV/�������ansduced ��ve�s, w�e�eas on�y a few 
�D1�pos���ve mac�op�ages we�e found �n �AAV/H��
1���ansduced ��ve�s ���gu�e 4A��. In con��as�, ��e�e was no 
significant change in the number of  ED2-positive (tissue-
�es�den��a��� mac�op�ages �n ��e ��ve�s of  CC�4���ea�ed �a�s. 
In cons�s�en� w��� ��e �mmuno��s�oc�em�ca� s�a�n�ngs, 
de�ec��on of  �n��a�epa��c mRNA �eve� by Rnase p�o�ec��on 
assay and se�um �eve�s of  MI� by ��ISA me��od s�owed 
s�gn�f�can� �educ��on of  ��e exp�ess�on �eve� of  MI� �n 
�AAV/H��1���ea�ed �a�s �n compa��son �o non���ea�men� 
o� �AAV/���� con��o�s �n = 3�5, P < 0.001, ��gu�es 4B 
and 4C��. 
To exam�ne ��e effec�s of  �AAV/H��1 on ��e f��
b�ogen�c p�ocess af�e� ��ve� �nju�y, we nex� exam�ned ��e 
Figure 4  A: The representative pictures of pro-inflammatory and pro-fibrogenic 
responses in the livers of rats with or without treatment at the 10th week. Infiltrating 
macrophage (ED1), tissue residential macrophages (ED2), TGF-β1, and activated 
hepatic stellate cells (desmin) were detected by immunohistochemistry; original 
magnification, ×100; B: The profile of pro-inflammatory and profibrogenic 
cytokine expression. The level of mRNA was detected by RNase protection assay 
and was quantified by phosphoimager, n = 3-5, aP<0.05; C: The plasma level of 
macrophage migration inhibitory factor (MIF) was detected by ELISA. The data 
were shown as fold changes of over the level in normal rat, n = 3-5, bP < 0.001.
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expression patterns of  pro-fibrogenic cytokine-TGF-β1, 
w��c� p�ays an �mpo��an� �o�e �n ��e ac��va��on and ��ans��
tion of  HSCs to myofibroblast-like cells after liver in�ury.       
Immunohistochemistry showed that TGF-β1 was highly 
exp�essed �n ��e po��a� ��ac� a�eas �n ��e ��ve�s of  �ong�
�e�m CC�4���ea�ed �a�s. In con��as�, on�y a m�n�ma� numbe� 
of  cells expressed TGF-β1 in rAAV/HO-1-transduced 
��ve�s of  �a�s unde� ��e same CC�4 p�o�oco� ���gu�e 4A��. 
��a�a��e� �o ��e �mmuno��s�oc�em�ca� s�a�n�ngs, RNase p�o�
tection assay also showed significant reduction in the tran�
script level of  TGF-β1 in rAAV/HO-1-transduced livers 
�n = 3�5, P < 0.001, Figure 4B). This finding was associated 
w��� ��e dec�eased numbe� of  ac��va�ed HSCs �desm�n�
pos���ve�� �n �AAV/H��1���ansduced ��ve�s ���gu�e 4A��.
dIScuSSIon
T�e�e �s a w�de �ange of  fac�o�s can �esu�� �n �epa�oce��
�u�a� �nju�y. Howeve�, ��e p��ma�y �esponse �ead�ng �o sub�
sequen� p�o��nf�amma�o�y and p�o�f�b�ogen�c �esponses 
�n ��ve� �s ex��ao�d�na�y s�m��a� [14]. Ana�ys�s of  c��n�ca� 
pa�ame�e�s based on ��e ��ea�men� of  p��ma�y ��ve� d�s�
ease s�owed encou�ag�ng �esu��s �n ��e dec�ease of  ��e 
severity of  liver fibrosis/cirrhosis [15,16]. Howeve�, none of  
anti-fibrotic treatment has been shown clinically effective. 
A numbe� of  ��e�apeu��c app�oac�es �a�ge��ng on an���
oxidant, anti-inflammatory response, suppression of  HSC 
ac��va��on, �nduc��on of  HSC apop�os�s o� �nc�ease of  ��e 
deg�ada��on of  ex��ace��u�a� ma���x �ave been s�own effec�
tive in the attenuation of  the severity of  liver fibrosis/cir�
��os�s �n va��ous an�ma� mode�s [14]. Mos� of  ��em, �owev�
e�, canno� eas��y ��ans�a�e �o ��e c��n�ca� se���ng, because ��e 
majo���y of  app�oac�es focus on ��e s�ng�e s�ep of  d�sease 
p�og�ess�on and ��e c��n�ca� s��ua��on �s fa� mo�e comp�ex 
��an ��a� �n ��e expe��men�a� se���ng. T�us, �� �s s���� u�ged 
to find out a therapeutic target that has multiple effects on 
d�sease p�og�ess�on and can be app��ed po�en��a��y �n ��e 
c��n�ca� se���ng. 
HO-1-mediated anti-apoptotic and anti-inflammatory 
ac��v���es a�e among ��e mos� a���ac��ve mec�an�sms �n 
ce��u�a� p�o�ec��on [17]. In fac�, H��1 on�y exp�esses �n a 
subpopu�a��on of  Kupffe� ce��s �n no�ma� ��ve�, w�e�eas a 
sma�� amoun� of  H��2 �s cons���u��ve�y be�ng exp�essed 
�n �epa�ocy�e [3,4]. None of  ��em exp�esses �n s�nuso�da� 
endo��e��a� ce��s and �epa��c s�e��a�e ce��s [3]. Howeve�, a 
significant increase in HO-1 expression was observed on 
��e w�o�e o�gan �eve� unde� s��ess cond���ons [4]. In ��e 
��ve� w��� acu�e �nju�y, H��1 was exp�essed �n ��e majo���y 
of  Kupffer cells and infiltrating macrophages, which might 
func��on as a feedbac� �oop �o con��o� ��e mac�op�age 
ac��va��on [18�20]. A���oug� ��e w�o�e H� ac��v��y �nc�eases 
d�ama��ca��y, ��e need fo� ��e ��ve� �o ove�come ��e �nsu��s 
of  ce��u�a� �nju�y seems �o be �e�a��ve�y �nsuff�c�en�. In�
c�eas�ng H� ac��v��y by �n��oduc��on of  exogenous H��1 
by rAAV/HO-1 in our model that significantly improved 
��e �ong��e�m ou�comes of  CC�4��nduced ��ve� c����os�s 
cou�d be based on �1�� ��e an���apop�o��c effec�s of  H��1 
on hepatocyte; (2) the anti-inflammatory effects of  HO-1 
on ��e con��o� of  ��e ce��u�a� �esponse of  �epa�ocy�e �n 






















































































































��ons and ��e supp�ess�on of  ��e mac�op�age ac��va��on; 
and �3�� ��e an���f�b�ogen�c effec�s of  H��1 on ��e sup�
p�ess�on of   ��e co��agen syn��es�s and/o� p�o��fe�a��on of  
ac��va�ed HSCs. 
Imp�ovemen� of  ��ve� func��on unde� �ong��e�m CC�4 
�ox�c��y by �AAV/H��1 may �ef�ec� ��e fac� ��a� ��e ex�
p�ess�on of  H��1 �n ��e �epa�ocy�e was ab�e �o p�even� 
��ve� damage, w��c� was suppo��ed by ��e down��egu�a��on 
of  p�o�apop�o��c genes and en�ancemen� of  ��ve� AT�� 
�eve� �n ou� mode�. In acu�e ��ve� �nju�y and �sc�em�a/
�epe�fus�on �nju�y of  ��ansp�an�ed ��ve�, �ecen� da�a sug�
ges�ed ��a� ��e �es�s�ance of  H��1 exp�ess�ng ce��s �o ��e 
p�o�apop�o��c s��mu�� m�g�� be d��ec��y ���oug� ��s en�y�
ma��c p�oduc� C� and/o� �nd��ec��y ���oug� ��e �nduc��on 
of  ��e �e2+�seques�e��ng p�o�e�n fe�����n. �xposu�e of  C� 
�o ��e p��ma�y �epa�ocy�e cou�d p�even� ��e �umo� nec�o�
sis factor-α-mediated and anti-CD95-mediated apoptotic 
even�s ���oug� ��e down��egu�a��on of  caspase�3 ac��v�
��y [21], w�e�eas ��e �nduc��on of  fe�����n supp�essed se�um�
dep��ved o� ox�da��ve s��ess�med�a�ed �epa�ocy�e apop�os�s 
by modu�a��on of  �n��ace��u�a� �e2+ �eve� and �n��b���on of  
�e2+�med�a�ed conve�s�on of  �yd�ogen pe�ox�de �n�o �H− and 
�H ���oug� ��e �en�on �eac��on [7,22]. In add���on �o an���
apop�o��c effec�s, H��1 cou�d a�so supp�ess ��e p�oduc�
��on of  p�o��nf�amma�o�y cy�o��ne�MI� p�oduc��on �n a 
�uman p��ma�y �epa�ocy�e cu��u�e �Tsu� TY, e� a�. unpub�
��s�ed da�a��. T��s may sugges� ��a� H��1 can func��on as 
�omeos�a��c mo�ecu�e �n ��e p�even��on of  apop�o��c even� 
and ��e con��o� of  ce��u�a� �esponse. 
H��1 can be �nduced �n va��ous ce�� �ypes �nc�ud�ng 
HSC ���oug� d��ec� o� �nd��ec� mec�an�sms. �u� da�a a�e 
cons�s�en� w��� a �ecen� f�nd�ng �n p��ma�y �uman HSC 
cu��u�e s�ow�ng ��a� ��e �nduc��on of  H��1 exp�ess�on �n 
HSC suppressed the transcript level of  pro-collagen 1α and 
se�um�med�a�ed HSC p�o��fe�a��on [23]. T��s may sugges� 
��a� H��1 can se�ve as a nega��ve �egu�a�o� �n ��e con��o� 
of  HSC ac��va��on and p�o��fe�a��on. T�us, �ess accumu�a�
tion of  fibrotic elements and prevention of  the develop�
men� of  po��a� �ype��ens�on �n �AAV/H��1���ansduced 
animals might reflect the outcomes of  cellular protection, 
anti-inflammatory and anti-fibrogenic responses. Although 
fu���e� �nves��ga��on �s needed �o c�a��fy ��e mec�an�sms 
�n mo�e de�a��s, �nc�eased H� ac��v��y �n ��ve� and sys�em�c 
effec�s of  ��e p�oduc�s of  H� en�yma��c ac��v��y can be 
��e �ey �n ��e con��o� of  ��e deve�opmen� of  c����os�s and 
po��a� �ype��ens�on �n ou� mode�. 
In conc�us�on, ou� da�a demons��a�ed ��a� en�ance�
men� ��e H� ac��v��y �n a s�ab�e manne� can supp�esses 
��e pa��op�ys�o�og�ca� c�anges of  c����os�s. In add���on, 
�AAV�med�a�ed gene ��ansfe� may �ep�esen� an a���ac��ve 
app�oac� �n con��o���ng ��e deve�opmen� of  c����os�s. 
Howeve�, fu���e� s�ud�es s�ou�d be ca���ed ou� �n o�de� 
�o answe� ��e ques��on of  w�e��e� ��e �AAV app�oac� �s 
su��ab�e fo� ��e �epa����s v��us�med�a�ed c��on�c ��ve� �nju�y 
and ��e subsequen� ou�come. 
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